Work

A randomised phase 3 trial to assess efficacy and safety of CAM2029, an octreotide subcutaneous depot, in patients with acromegaly

Year: 2024

Type: conference-abstract

Source: Endocrine Abstracts

DOI: 10.1530/endoabs.99.p326

Authors: Diego Ferone, Julie Silverstein, Pamela Freda, Laurence Katznelson, Federico Gatto, Pinar Kadioglu, Pietro Maffei, Jochen Seufert, Spencer-Segal Joanna L., Elena Isaeva, Alexander Dreval, Maria Harrie, Agneta Svedberg, Fredrik Tiberg

Language: English

Topic: Pituitary Gland Disorders and Treatments

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4396741829

Cites:

Cited by:

Related to: 10